To further investigate the relationship between different types of survival, more specifically PFS and DFS, and expression of ANTXR1 in bladder cancer patients, we analyzed the probability of survival for bladder cancer patients according to these parameters. This evidence concerns the gene ANTXR1 and urinary bladder carcinoma.